Quality of evidence about effectiveness of treatments for metastatic uveal melanoma

Transactions of the American Ophthalmological Society

Volumn 106, Issue , 2008, Pages 128-135

  Augsburger, James J ^a   Corrêa, Zélia M ^a   Shaikh, Adeel H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHOROID MELANOMA; CILIARY BODY MELANOMA; CILIOCHOROIDAL MELANOMA; CONTROLLED STUDY; EYE CANCER; EYE MELANOMA; HUMAN; INTRAOCULAR MELANOMA; IRIDOCILIARY MELANOMA; IRIS MELANOMA; MAJOR CLINICAL STUDY; METASTATIC UVEAL MELANOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UVEA MELANOMA; EPIDEMIOLOGY; IMMUNOTHERAPY; LIVER TUMOR; MELANOMA; META ANALYSIS; METASTASIS; MORTALITY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIOTHERAPY; SKIN TUMOR; SURVIVAL RATE; TREATMENT OUTCOME; UVEA TUMOR;

ANTINEOPLASTIC AGENTS; BIAS (EPIDEMIOLOGY); CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; MELANOMA; RADIOTHERAPY; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 63049123398     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Diener-West M, Reynolds SM, Agugliaro DJ, et al (Collaborative Ocular Melanoma Study Group). Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma. Arch Ophthalmol 2005;123:1639-1643.
2. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 1995;76:1665-1670.
3. Nathan FE, Berd D, Sato T, et al. BOLD + interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res 1997;16:201-208.
4. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000;89:1561-1568.
5. Egerer G, Lehnert T, Max R, Naeher H, Keilholz U, Ho AD. Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients. Int J Clin Oncol 2001;6:25-28.
6. Char DH. In discussion of: Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991;98:383-390.
7. Albert DM, Niffenegger AS, Willson JKY. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 1992;36:429-438.
8. Robertson DM. Cytogenetics in the management of uveal melanoma. Are we there yet? Arch Ophthalmol 2008;126:409-410.
9. Brighton B, Bhandari M, Tornetta P, Felson DT. Heirarchy of evidence: from case reports to randomized controlled trials. Clin Orthop Relat Res 2003;413:19-24.
10. Pyrhönen S. The treatment of metastatic uveal melanoma. Eur J Cancer 1998;34 (Suppl 3):S27-S30.
11. Wöll E, Bedikian A, Legha SS. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res 1999;9:575-581.
12. Jäckel A, Bock M, Deichmann M, Waldmann V, Näher H. Therapy of metastatic malignant uveal melanoma. Hautarzt 2001;52:98-103.
13. De Croock L, Verbraeken H. Metastatic uveal melanoma: diagnosis and treatment. A literature review. Bull Soc Belge Ophtalmol 2002;286:59-63.
14. Feldman ED, Pingpank JF, Alexander HR. Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol 2004;11:290-297.
15. Rousseau AP. Uveal melanoma: update and future directions. Can J Ophthalmol 2004;39:335-342.
16. Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am 2005;18:143-150.
17. Bedikian AY. Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin 2006;46:151-166.
18. Kivelä T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin 2006;46:133-149.
19. Cunningham JD, Cirincione E, Ryan A, Canin-Endres J, Brower S. Indications for surgical resection of metastatic ocular melanoma. A case report and review of the literature. Int J Pancreatol 1998;24:49-53.
20. Terheyden P, Kämpgen E, Rünger TM, Bröcker EB, Becker JC. Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature. Hautarzt 1998;49:770-773.
21. Fournier GA, Albert DM, Arrigg CA, Cohen AM, Lamping KA, Seddon JM. Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol 1984;102:80-82.
22. Gronemeyer U, Engemann R, Thiede A. Successful removal of a liver metastasis 15 years after enucleation for choroidal melanoma. Fortschr Ophthalmol 1984;81:363-364.
23. Shields JA, Augsburger JJ, Donoso LA, Bernardino VB, Portenar M. Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol 1985;100:666-668.
24. Carrasco CH, Wallace S, Charnsangavej C, Papadopoulos NE, Patt YZ, Mavligit GM. Treatment of hepatic metastases in ocular melanoma. Embolization of the hepatic artery with polyvinyl sponge and cisplatin. JAMA 1986;255:3152-3154.
25. Tishler M, Greif J, Topilsky M. Solitary pulmonary metastasis of choroidal malignant melanoma simulating primary lung cancer. Eur J Respir Dis 1986;68:215-217.
26. Shields JA, Shields CL, Augsburger JJ, Negrey JN. Solitary metastasis of choroidal melanoma to the contralateral eyelid. Ophthal Plast Reconstr Surg 1987;3:9-12.
27. Coupland SE, Sidiki S, Clark BJ, McClaren K, Kyle P, Lee WR. Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation. Arch Ophthalmol 1996;114:751-756.
28. Gündüz K, Shields JA, Shields CL, Sato T, Mastrangelo MJ. Surgical removal of solitary hepatic metastasis from choroidal melanoma. Am J Ophthalmol 1998;125:407-409.
29. Midena E, de Belvis V, Dei Tos AP, Antonini C. Isolated brain metastasis of malignant choroidal melanoma 27 years after enucleation. Arch Ophthalmol 1999;117:1553-1556.
30. Shields JA, Perez N, Shields CL, Singh AD, Eagle RC. Orbital melanoma metastatic from contralateral choriod: management by complete surgical resection. Ophthalmic Surg Lasers 2002;33:416-420.
31. Soni S, Lee DS, DiVito J, et al. Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide. J Pediatr Hematol Oncol 2002;24:488-491.
32. Duh EJ, Schachat AP, Albert DM, Patel SM. Long-term survival in a patient with uveal melanoma and liver metastasis. Arch Ophthalmol 2004;122:285-287.
33. Achtaropoulos AK, Mitzos AP, Detorakis ET, Georgakoulias NV, Drakonaki EE, Kozobolis VP. Late isolated brain metastasis following enucleation for choroidal melanoma. Ophthalmic Surg Lasers Imaging 2005;36:151-154.
34. Berger TG, Diekmann D, Efferth T, et al. Artesnuate in the treatment of metastatic uveal melanoma - first experience. Oncol Rep 2005;14:1599-1603.
35. Saraiva VS, Rodriguez-Reyes AA, Chen MF, Saraiva EJ, Burnier MN. Metastatic choroidal melanoma presenting as a solitary pulmonary nodule. Can J Ophthalmol 2005;40:72-74.
36. Ueda H, Hamagami H, Tanaka H, Kida Y, Ichinose M. Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver. Oncol Rep 2005;14:1543-1546.
37. Bourla DH, Young TA. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye. Semin Ophthalmol 2007;22:175-177.
38. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Höffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993;72:2219-2223.
39. Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 2006;13:712-720.
40. Siegel R, Hauschild A, Kettelhack C, Kahler KC, Bembenek A, Schlag PM. Hepatic arterial foremustine chemotherapy in patients with liver metastasis from cutaneous melanoma is as effective as in ocular melanoma. Eur J Surg Oncol 2007;33:627-632.
41. Bedikian AY, Kantarjian H, Young SE, Bodey GP. Prognosis in metastatic choroidal melanoma. South Med J 1981;74:574-577.
42. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer 1983;52:334-336.
43. Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK. Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol 1998;21:568-572.
44. Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S, Kivelä T. A prognostic model and staging for metastatic uveal melanoma. Cancer 2003;97:465-475.
45. Kodjikian L, Grange JD, Baldo S, Baillif S, Garweg JG, Rivoire M. Prognostic factors of liver metastases from uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2005;243:985-993.
46. Rivoire M, Kodjikian L, Baldo S, Kaemmerlen P, Nägrier S, Grange JD. Treatment of liver metastases from uveal melanoma. Ann Surg Oncol 2005;12:422-428.
47. Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991;98:383-389.
48. Hseuh EC, Essner R, Foshag LJ, Ye X, Wang HJ, Morton DL. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer 2004;100:122-129.
49. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol 2005;23:8076-8080.
50. Solti M, Berd D, Mastrangelo MJ, Sato T. A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment. Melanoma Res 2007;17:225-231.
51. Vogl T, Eichler K, Zangos S, et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malingnant melanoma: local tumor control and survival. J Cancer Res Clin Oncol 2007;133:177-184.
52. Keilholz U, Schuster R, Schmittel A, et al. A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours. Eur J Cancer 2004;40:2047-2052.
53. Corrie PG, Shaw J, Panswick VJ, et al. Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. Br J Cancer 2005;92;1997-2003.
54. Mavligit GM, Charnsangavej C, Carrasco CH, Patt YZ, Benjamin RS, Wallace S. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 1988;260:974-976.
55. Leyvraz S, Spataro V, Bauer J, et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997;15:2589-2595.
56. Salmon RJ, Levy C, Plancher C, et al. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol 1998;24:127-130.
57. Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2000;6:3062-3070.
58. Alexander HR, Libutti SK, Pingpank JF, et al. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2003;9:6343-6349.
59. Kivelä T, Suciu S, Hansson J, et al. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer 2003;39:1115-1120.
60. Noter SL, Rothbarth J, Pijl ME, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 2004;14:67-72.
61. Pyrhönen M, Hahka-Kemppinen M, Muhonen T. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. J Clin Oncol 1992;10:1919-1926.
62. Cantore M, Fiorentini G, Aitini E, Davitti B, et al. Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumori 1994;80:37-39.
63. Proebstle TM, Scheibenbogen C, Sterry W, Keilholz U. A phase II study of dacarbazine, cisplatin, interferon-alpha and high dose interleukin-2 in 'poor risk' metastatic melanoma. Eur J Cancer 1996;32A:1530-1533.
64. Becker JC, Terheyden P, Kämpgen E, et al. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 2002;87:840-845.
65. Ellerhorst JA, Bedikian AY, Smith TM, Papadopoulos NE, Plager C, Eton O. Phase II trial of 9-netrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma. Anticancer Drugs 2002;13:169-172.
66. Pyrhönen S, Hahka-Kemppinen M, Muhonen T, et al. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) and human leukocyte interferon for metastatic uveal melanoma. Cancer 2002;95:2366-2372.
67. Pföhler C, Cree IA, Ugurel S, et al. Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study. Anticancer Drugs 2003;14:337-340.
68. Schmidt-Hieber M, Schmittel A, Thiel E, Keilholz U. A phase II study of bendamustine chemotherapy as second-line treatment in metastatic uveal melanoma. Melanoma Res 2004;14:439-442.
69. Patel K, Sullivan K, Berd D, Mastrangelo MJ, Shields JA, Sato T. Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 2005;15:297-304.
70. Schmittel A, Scheulen ME, Bechrakis NE, et al. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. Melanoma Res 2005;15:205-207.
71. Schmittel A, Schmidt-Hieber M, Martus P, et al. A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma. Ann Oncol 2006;17:1826-1829.
72. O'Neill PA, Butt M, Eswar CV, Gillis P, Marshall E. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. Melanoma Res 2006;16:245-248.
73. Peters S, Voelter V, Zografos L, et al. Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol 2006;17:578-583.
74. Schmittel A, Schuster R, Bechrakis NE, et al. A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma. Melanoma Res 2005;15:447-451.
75. Augsburger JJ, Schneider S, Freire J, Brady LW. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987. Graefes Arch Clin Exp Ophthalmol 1999;237:558-567.
76. Feinstein AR. Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia: Saunders; 1985:323-324, 460-462.
77. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-1129.